YSOPIA Bioscience Announces First Signs of Biological Activity from Phase I Analysis of Xla1, its...
Dec 2, 2021
more +Eposter / Safety Evaluation of Christensenella minuta as a Novel Microbiome-based Biotherapy to Treat...
Nov 1, 2021
more +YSOPIA Bioscience Announces Leadership Team Reorganization and Appoints Co-Founder & CFO Fabrice...
Nov 1, 2021
more +EMA & FDA Apply a Similar Mindset When Providing Scientific Advice For Live Biotherapeutic...
Sep 13, 2021
more +